You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Suppliers and packagers for LARYNG-O-JET KIT


✉ Email this page to a colleague

« Back to Dashboard


LARYNG-O-JET KIT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Intl Medication LARYNG-O-JET KIT lidocaine hydrochloride SOLUTION;TOPICAL 086364 ANDA HF Acquisition Co LLC, DBA HealthFirst 51662-1553-3 25 POUCH in 1 CASE (51662-1553-3) / 1 VIAL in 1 POUCH (51662-1553-2) / 4 mL in 1 VIAL 2021-06-14
Intl Medication LARYNG-O-JET KIT lidocaine hydrochloride SOLUTION;TOPICAL 086364 ANDA International Medication Systems, Limited 76329-6300-5 25 VIAL in 1 CARTON (76329-6300-5) / 4 mL in 1 VIAL 2012-06-19
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Last updated: August 5, 2025

ppliers for the Pharmaceutical Drug: LARYNG-O-JET KIT

Introduction
The LARYNG-O-JET KIT is a specialized medical device integral to emergency airway management, primarily employed for rapid administration of medications during critical situations such as anaphylaxis, airway obstruction, or mixed respiratory emergencies. As a device rather than a conventional pharmaceutical, the LARYNG-O-JET KIT involves sophisticated design components alongside medicinal agents. Identifying reliable suppliers and understanding the distribution channels are critical for healthcare providers, procurement agencies, and pharmaceutical corporations aiming to ensure availability, compliance, and quality assurance.

Product Overview: The LARYNG-O-JET KIT
The LARYNG-O-JET KIT comprises a specialized jet injector system designed for intralaryngeal medication delivery, enabling swift, needleless administration of drugs directly into the laryngeal tissues. The kit typically includes the jet injector device, sterile medication cartridges, mounting accessories, and detailed instructions. The device is engineered for single-use or limited-use scenarios, emphasizing safety, compatibility with various medications, and ease of operation in emergency environments.

Manufacturers and Patent Holders
The origin of the LARYNG-O-JET KIT traces back to pioneering companies that developed jet injection technology tailored for airway medicine.

  • Teleflex Incorporated
    A leading medical device manufacturer, Teleflex owns the rights for certain jet injector technologies, including those used for intralaryngeal applications. They produce and market devices akin to the LARYNG-O-JET, emphasizing minimally invasive, needleless drug delivery. Their products are widely distributed through global medical supply chains.

  • Intersurgical Ltd.
    Known for respiratory and anesthesia equipment, Intersurgical supplies jet injection devices intended for airway management. While not exclusively branded as the LARYNG-O-JET, their products are part of the broader jet delivery system sphere.

  • Others and Patent Licensing
    The original patents for jet injector med-tech, encompassing the LARYNG-O-JET technology, are often licensed or acquired by various regional manufacturers. These include smaller specialized medical device companies or regional distributors.

Key Suppliers and Distributors

  1. Teleflex Incorporated

    • Product Lines: The LARYNG-O-JET is marketed under the Auriel or similar branding, providing emergency airway medicament delivery solutions.
    • Distribution Channels: Teleflex distributes via their global network, including direct sales to hospital systems, government emergency services, and authorized medical distributors.
    • Availability: Highly accessible in North America, Europe, and Asia-Pacific through authorized medical suppliers.
  2. Intersurgical Ltd.

    • Product Lines: Offers jet injection devices suitable for airway management.
    • Distribution Channels: Distributed via regional agents and international medical equipment resellers.
    • Availability: Widely available across healthcare systems worldwide, especially in Europe and Asia.
  3. BD (Becton Dickinson)

    • Product Lines: Known for syringe and injection technologies, including jet injectors in some segments.
    • Distribution Channels: Through their global healthcare supply network, BD supplies devices compatible with emergency medical protocols.
  4. Regional Medical Supply Companies
    Numerous regional vendors supply compatible jet injector systems, often tailored for local healthcare regulations and procurement standards.

Suppliers of Medications for LARYNG-O-JET KIT
Though the device is primary hardware, the efficacy depends on compatible medications, which include:

  • Epinephrine (for anaphylaxis)

    • Suppliers: Mylan, Teva Pharmaceuticals, and Hikma Pharmaceuticals are primary manufacturers of epinephrine auto-injectables and vials suitable for jet injection.
    • Distribution: Available through wholesale pharmaceutical distributors, hospital pharmacies, and direct procurement.
  • Other Medications

    • Lidocaine, Atropine, and Vasopressors—these can be formulated for compatibility with jet injection systems.
    • Suppliers: Major global pharmaceutical companies such as Pfizer, Novartis, and Sanofi.

Regulatory and Quality Standards
All suppliers must comply with regulatory standards such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regional authorities. The devices are typically classified as Class III medical devices, requiring rigorous compliance with ISO 13485 medical device quality management standards.

Supply Chain Considerations
For procurement, organizations should prioritize suppliers with verified Good Manufacturing Practice (GMP) certification, transparent quality assurance processes, and proven distribution logistics. Many of these suppliers maintain emergency stock allocations, enabling rapid deployment.

Challenges in Supplier Procurement

  • Patent and Licensing Restrictions: Some technology components are proprietary, limiting direct manufacturing rights.
  • Regulatory Approvals: Variability in regional approvals can influence device and medication availability.
  • Supply Chain Disruptions: As observed during global crises, procurement chains for specialized medical devices and medications face disruptions.

Future Trends and Alternatives
The market is evolving with innovations in portable emergency airway management devices. Alternatives include portable aerosolized drug delivery systems and automated intralaryngeal injection devices developed by startups and established players, broadening the supplier base.

Conclusion
The primary suppliers for the LARYNG-O-JET KIT include Teleflex Incorporated and Intersurgical Ltd., both recognized for their technological leadership in airway management devices. Supplementing these are regional medical device manufacturers and leading pharmaceutical firms supplying compatible medications. Understanding the supply landscape, regulatory standards, and logistical channels enables healthcare providers and procurement entities to ensure reliable access, maintain compliance, and facilitate effective emergency care.


Key Takeaways

  • The LARYNG-O-JET KIT is primarily supplied by established medical device manufacturers like Teleflex and Intersurgical.
  • Compatible medications such as epinephrine are supplied by global pharmaceutical giants and require handling in accordance with regional regulations.
  • Ensuring device and medication procurement aligns with GMP and ISO standards is essential for safety and efficacy.
  • The supplier landscape is evolving, with technological innovations expanding options for emergency airway management.
  • Collaboration with regional distributors and adherence to regulatory standards are critical for uninterrupted supply.

FAQs

  1. Who are the main global suppliers of the LARYNG-O-JET KIT?
    Major global suppliers include Teleflex Incorporated and Intersurgical Ltd., both providing jet injection systems compatible with emergency airway management protocols.

  2. Are medications used with the LARYNG-O-JET KIT available from multiple suppliers?
    Yes, medications like epinephrine are produced by several leading pharmaceutical companies including Mylan, Teva, and Hikma Pharmaceuticals, facilitating diverse sourcing options.

  3. What regulatory standards ensure the safety of LARYNG-O-JET KIT supplies?
    Compliance with ISO 13485, FDA approvals, and EMA certifications ensures product safety, quality, and efficacy.

  4. Can regional distributors supply the LARYNG-O-JET KIT internationally?
    Yes, regional medical supply companies often act as authorized distributors, especially for emerging markets or regions with specific regulatory standards.

  5. Are there ongoing innovations in jet injector technology for airway management?
    Yes, startups and established manufacturers are developing portable, automated devices to enhance emergency airway procedures, expanding the supplier ecosystem beyond traditional players.


References
[1] Teleflex Incorporated — Official Website, Medical Devices Division.
[2] Intersurgical Ltd. — Product Portfolio and Distribution Channels.
[3] ISO 13485 Medical Devices Quality Management Systems.
[4] FDA Medical Devices Database and Regulatory Filings.
[5] World Health Organization (WHO) Medical Equipment Procurement Guidelines.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.